Patent: 9,642,872

Try a free trial

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,642,872

Title:	Treatment of B-cell lymphoma with microRNA
Abstract:	The invention relates to microRNA-34a and related microRNAs for use in the treatment of B-cell lymphoma. Likewise it relates to microRNA-34a for use in the preparation of a medicament for the treatment of B-cell lymphoma, and for a method of treatment of B-cell lymphoma comprising administering microRNA-34a. These claims are based on the observation that microRNA-34a shows strong anti-proliferative effects when overexpressed in diffuse large B-cell lymphoma (gDLBCL) cell lines, or when delivered intratumorally or systemically in xenograft models of DLBCL.
Inventor(s):	Craig; Vanessa (Zurich, CH), Mueller; Anne (Dubendorf, CH)
Assignee:	UNIVERSITY OF ZURICH (Zurich, CH)
Application Number:	14/565,049
Patent Claims:	see list of patent claims

Details for Patent 9,642,872

Glossary

Subscribe to access the full database, or request a copy of the full page.
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Genentech	RITUXAN	rituximab	VIAL	103705	001	1997-11-26	➤ Sign Up	UNIVERSITY OF ZURICH (Zurich, CH)	2030-09-30	RX		search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patent Family for US Patent 9,642,872

Subscribe to access the full database, or request a copy of the full page.
Country	Patent Number	Publication Date
European Patent Office	2622076	Aug 07, 2013
United States of America	2013195858	Aug 01, 2013
United States of America	2015322430	Nov 12, 2015
>Country	>Patent Number	>Publication Date

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.